---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-035783"
form_type: "8-K"
ticker: "SMTI"
cik: "0000714256"
company_name: "Sanara MedTech Inc."
filed_at: "2024-09-11T23:59:59+00:00"
generated_at: "2026-05-31T05:31:28.729124+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Sanara invests $5M for 6.6% of ChemoMouthpiece, exclusive U.S. distribution via InfuSystem JV

## Summary
- Sanara CMP purchased 100,674.72 common units in ChemoMouthpiece for $5.0 million, a 6.64% ownership stake.
- SI Technologies (50/50 JV with InfuSystem) appointed sole U.S. distributor of ChemoMouthpiece kits for 5 years.
- SI Technologies has an option to purchase ChemoMouthpiece's U.S. business, including IP, expiring Jan 31, 2029.
- Sanara borrowed an additional $15.5M under its CRG term loan at 13.25% per annum, maturing May 30, 2029.
- Proceeds used for the ChemoMouthpiece investment; remaining funds for acquisitions and working capital.

## SEC filing metadata
- accession: 0001493152-24-035783
- form_type: 8-K
- ticker: SMTI
- cik: 0000714256
- company_name: Sanara MedTech Inc.
- filed_at: 2024-09-11T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01, 8.01, 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/714256/000149315224035783/0001493152-24-035783-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/714256/000149315224035783/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-035783
- JSON: https://secwatch.observer/filing/0001493152-24-035783.json
- Plain text: https://secwatch.observer/filing/0001493152-24-035783.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.